Medico Remedies Financials

NSE: MEDICO | BSE: 540937

₹37.05

₹1.63 (4.60%)

As on 11-Sep-2026IST

Market cap

₹305 Cr

Revenue (TTM)

₹238 Cr

P/E Ratio

22.1

P/B Ratio

3.9

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Operating Revenue	237.53	206.38	150.94	144.92	140.44	121.02
Total Income	243.97	212.31	154.21	147.05	144.52	123.05
Total Expenditure	220.02	189.35	136.52	132.01	130.96	113.69
EBITDA	17.50	17.03	14.42	12.91	9.48	7.33
Depreciation	3.05	3.09	3.03	2.88	2.72	2.22
EBIT	14.45	13.93	11.39	10.03	6.76	5.12
Interest	1.93	1.81	1.16	0.82	0.75	0.66
Other Income	6.45	5.93	3.27	2.13	4.09	2.03
Exceptional Items	--	--	--	--	--	--
Profit before Tax	18.97	18.06	13.50	11.33	10.10	6.48
Provision for Tax	5.15	4.94	3.41	3.04	2.86	1.67
Profit after Tax	13.82	13.12	10.09	8.29	7.24	4.81

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Shareholder's Funds	75.48	75.47	62.47	52.37	43.84	36.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.29	-0.11	0.37	1.26	2.08	2.50
Current Liabilities	77.64	77.64	56.71	44.58	43.15	39.57
Total Liabilities	153.40	153.40	119.80	98.21	89.08	78.84

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Non-Current Assets	23.15	24.09	22.88	22.48	22.91	19.65
Current Assets	128.92	128.92	96.68	75.73	66.17	59.01
Total Assets	153.40	153.40	119.80	98.21	89.08	78.84
Total Debt*	--	18.91	13.83	6.75	8.09	10.62
Net Current Assets	51.28	51.27	39.96	31.15	23.02	19.43
Contingent Liabilities	--	3.36	0.11	0.23	0.23	--

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Cash From Operating Activities	--	5.87	4.89	2.44	8.17	5.86
Cash Flow from Investing Activities	--	-4.51	-3.46	-2.68	-6.60	-1.76
Cash from Financing Activities	--	-0.55	-0.52	-0.49	-1.82	-5.77
Net Cash Inflow / Outflow	--	0.81	0.91	-0.73	-0.25	-1.67

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Adjusted EPS (₹)	1.66	1.58	1.22	1.00	0.87	0.58
Cash EPS (₹)	1.66	1.95	1.58	1.35	1.20	0.85
Adjusted Book Value (₹)	9.40	9.10	7.53	6.31	5.28	4.41
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.71	0.59	0.29	0.98	3.53
Free Cash Flow per Share (₹)	--	0.17	0.32	-0.09	0.15	-0.14

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
ROCE (%)	--	23.28	21.65	21.90	21.88	15.09
ROE (%)	19.41	19.02	17.58	17.23	18.01	13.94
ROA (%)	10.11	9.62	9.27	8.85	8.63	6.24
EBIT Margin (%)	6.08	6.75	7.55	6.92	4.81	4.23
Net Margin (%)	5.66	6.18	6.55	5.64	5.01	3.91
Cash Profit Margin (%)	--	7.85	8.69	7.71	7.09	5.81

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Revenue Growth (%)	49.96	36.73	4.15	3.19	16.04	-1.12
EBIT Growth (%)	20.74	22.31	13.57	48.36	32.14	42.51
Net Profit Growth (%)	33.73	29.94	21.74	14.49	50.49	85.79
EPS Growth (%)	33.73	29.94	21.74	14.50	50.47	85.84
Book Value Growth (%)	--	20.82	19.28	19.45	19.87	12.68

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Price / Earnings	22.06	20.65	42.83	49.32	85.61	5.79
Price / Book Value	3.91	3.59	6.92	7.81	14.14	3.81
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	13.44	12.54	25.16	27.63	46.22	15.77
Close Price (₹)	38.61	32.76	51.57	48.10	75.05	16.80
High Price (₹)	56.99	62.48	79.83	100.79	87.75	29.87
Low Price (₹)	30.22	30.22	34.80	44.55	16.00	5.00
Market Cap (₹ Cr)	304.80	270.87	432.34	408.95	619.89	139.41

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debt to Equity	0.00	0.25	0.22	0.13	0.18	0.29
Short term debt to equity ratio	--	0.25	0.22	0.12	0.18	0.25
Current Ratio	1.66	1.66	1.70	1.70	1.53	1.49
Quick Ratio	1.27	1.27	1.23	1.33	1.08	1.03
Interest Coverage	10.82	11.00	12.66	14.76	14.52	10.79

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debtors to sales (%)	34.52	39.73	37.88	34.25	25.70	25.11
Asset Turnover	1.74	1.51	1.39	1.55	1.67	1.57
Receivable days	--	123.07	129.15	107.96	86.40	87.18
Inventory Days	--	50.18	52.07	45.38	49.13	49.25
Payable days	--	120.69	131.82	119.19	120.01	135.32
Cash Conversion Cycle	--	52.56	49.39	34.15	15.53	1.11

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)